跳至主要内容
临床试验/EUCTR2022-001909-53-BE
EUCTR2022-001909-53-BE进行中(未招募)1 期

ong Term (>30 months following wound closure) assessments of cosmesis, function and quality of life in pediatric subjects following participation in study MW2012-01-01 evaluating the efficacy and safety of NexoBrid as compared to standard of care (SOC) treatment

MediWound Ltd.0 个研究点目标入组 9 人开始时间: 2022年6月30日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
9

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1. Subjects who were treated for eschar removal in study MW2012-01-01.
  • 2. Signed written informed consent by Patient or by a guardian, when applicable.
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 7
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 2
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 未提供

研究者

相似试验